|Articles|February 9, 2022
Retrofit Pharmaceutical Equipment for High Containment and Reduced Risk of Cross Contamination
Author(s)ILC Dover
With the growth of highly potent active pharmaceutical ingredients (HPAPIs) and multiple-use facilities that must protect against product cross contamination, the need for engineering controls to achieve high containment has become more critical.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV
3
GSK’s RSV Vaccine Approved in Europe
4
How Digitalization Is Transforming Pharmaceutical Manufacturing Processes
5